Literature DB >> 2544661

Genotypic selection following coinfection of cultured cells with subgroup 1 and subgroup 2 human rotaviruses.

R L Ward1, D R Knowlton.   

Abstract

The purpose of this study was to determine why identifiable reassortants between subgroup 1 and subgroup 2 rotaviruses have been so rarely isolated from human specimens. Cultured cells were coinfected with pairs of subgroup 1 and 2 human rotaviruses and passaged multiple times to simulate natural reassortant formation and selection in vivo. After coinfection of MA-104 cells with subgroup 1 (DS-1) and subgroup 2 (either Wa or P) strains, approximately 14% of the plaque-picked progeny were shown to be reassortants. During multiple passages of these coinfected cultures, however, complete (Wa virus coinfection) or nearly complete (P virus coinfection) loss of detectable DS-1 segments from progeny was observed. Thus, when all segments of the subgroup 2 viruses were present in coinfected cultures, these segments dominated in the selected progeny. Coinfection with subgroup 1-subgroup 2 rotavirus reassortants and the DS-1 strain followed by multiple passages, however, resulted in complete loss of some segments from the subgroup 2 strains originally present in the reassortants. Therefore, segments from the parental subgroup 2 viruses appeared to be selected in toto during multiple passages because they were dominant as a group, not because individual segments of these viruses were consistently favoured over their subgroup 1 virus counterparts.

Entities:  

Mesh:

Year:  1989        PMID: 2544661     DOI: 10.1099/0022-1317-70-7-1691

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

1.  Human rotavirus strain with unique VP4 neutralization epitopes as a result of natural reassortment between members of the AU-1 and Wa genogroups.

Authors:  O Nakagomi; E Kaga; T Nakagomi
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  Evidence for natural reassortants of human rotaviruses belonging to different genogroups.

Authors:  R L Ward; O Nakagomi; D R Knowlton; M M McNeal; T Nakagomi; J D Clemens; D A Sack; G M Schiff
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

3.  Molecular evidence for naturally occurring single VP7 gene substitution reassortant between human rotaviruses belonging to two different genogroups.

Authors:  O Nakagomi; T Nakagomi
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

4.  Formation and selection of intergenogroup reassortants during cell culture adaptation of rotaviruses from dually infected subjects.

Authors:  R L Ward; O Nakagomi; D R Knowlton; M M McNeal; T Nakagomi; N Huda; J D Clemens; D A Sack
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

5.  G (VP7) serotype-dependent preferential VP7 gene selection detected in the genetic background of simian rotavirus SA11.

Authors:  N Kobayashi; K Taniguchi; K Kojima; T Urasawa; S Urasawa
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

6.  Effect of the selection pressure with anti-VP7 and anti-VP4 neutralizing monoclonal antibodies on reassortant formation between two human rotaviruses.

Authors:  N Kobayashi; K Taniguchi; T Urasawa; S Urasawa
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

7.  Recurrent circulation of single nonstructural gene substitution reassortants among human rotaviruses with a short RNA pattern.

Authors:  E Kaga; O Nakagomi
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

8.  Reconciliation of rotavirus temperature-sensitive mutant collections and assignment of reassortment groups D, J, and K to genome segments.

Authors:  Jeanette Criglar; Harry B Greenberg; Mary K Estes; Robert F Ramig
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

9.  Naturally occurring dual infection with human and bovine rotaviruses as suggested by the recovery of G1P8 and G1P5 rotaviruses from a single patient.

Authors:  O Nakagomi; Y Isegawa; R L Ward; D R Knowlton; E Kaga; T Nakagomi; S Ueda
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.